Disclosed positions

Estimated from their latest filings — positions may have changed since

$4.82M

combined est. value

Stock	Shares	Price	Value	Weight	As of
ADPTAdaptive Biotechnologies Corp	221,278	$21.80	$4.82M	100%	2026-06-29

ADPT

Adaptive Biotechnologies Corp

$4.82M

221,278 sh

All filings on record

Every Form 4 transaction we track for this filer

all 21buys 0sells 5

Stock	Transaction	Date	~6mo later
ADPTAdaptive Biotechnologies Corp	Sell $3.27M · 154,768 sh	2026-06-29	—
ADPTAdaptive Biotechnologies Corp	Exercise $418.7K · 51,570 sh	2026-06-29	—
ADPTAdaptive Biotechnologies Corp	Exercise $99.5K · 24,944 sh	2026-06-29	—
ADPTAdaptive Biotechnologies Corp	Exercise $211.0K · 24,944 sh	2026-06-29	—
ADPTAdaptive Biotechnologies Corp	Exercise $22.3K · 1,837 sh	2026-06-29	—
ADPTAdaptive Biotechnologies Corp	Sell $231.7K · 11,034 sh	2026-06-26	—
ADPTAdaptive Biotechnologies Corp	Exercise $134.0K · 11,034 sh	2026-06-26	—
ADPTAdaptive Biotechnologies Corp	Sell $212.4K · 12,604 sh	2025-12-04	—
ADPTAdaptive Biotechnologies Corp	Exercise $16.6K · 4,157 sh	2025-12-04	—
ADPTAdaptive Biotechnologies Corp	Exercise $35.2K · 4,157 sh	2025-12-04	—
ADPTAdaptive Biotechnologies Corp	Exercise $52.1K · 4,290 sh	2025-12-04	—
ADPTAdaptive Biotechnologies Corp	Sell $5.22M · 308,477 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Exercise $331.7K · 83,145 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Exercise $1.45M · 119,809 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Exercise $249.9K · 34,375 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Exercise $324.1K · 49,480 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Exercise $136.5K · 20,834 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Exercise $5.2K · 834 sh	2025-11-21	—
ADPTAdaptive Biotechnologies Corp	Sell $4.93M · 297,925 sh	2025-11-20	—
ADPTAdaptive Biotechnologies Corp	Exercise $837.2K · 68,961 sh	2025-11-20	—
ADPTAdaptive Biotechnologies Corp	Exercise $1.13M · 133,032 sh	2025-11-20	—

ADPTSell

2026-06-29 · Adaptive Biotechnologies Corp

$3.27M

—

ADPTExercise

2026-06-29 · Adaptive Biotechnologies Corp

$418.7K

—

ADPTExercise

2026-06-29 · Adaptive Biotechnologies Corp

$99.5K

—

ADPTExercise

2026-06-29 · Adaptive Biotechnologies Corp

$211.0K

—

ADPTExercise

2026-06-29 · Adaptive Biotechnologies Corp

$22.3K

—

ADPTSell

2026-06-26 · Adaptive Biotechnologies Corp

$231.7K

—

ADPTExercise

2026-06-26 · Adaptive Biotechnologies Corp

$134.0K

—

ADPTSell

2025-12-04 · Adaptive Biotechnologies Corp

$212.4K

—

ADPTExercise

2025-12-04 · Adaptive Biotechnologies Corp

$16.6K

—

ADPTExercise

2025-12-04 · Adaptive Biotechnologies Corp

$35.2K

—

ADPTExercise

2025-12-04 · Adaptive Biotechnologies Corp

$52.1K

—

ADPTSell

2025-11-21 · Adaptive Biotechnologies Corp

$5.22M

—

ADPTExercise

2025-11-21 · Adaptive Biotechnologies Corp

$331.7K

—

ADPTExercise

2025-11-21 · Adaptive Biotechnologies Corp

$1.45M

—

ADPTExercise

2025-11-21 · Adaptive Biotechnologies Corp

$249.9K

—

ADPTExercise

2025-11-21 · Adaptive Biotechnologies Corp

$324.1K

—

ADPTExercise

2025-11-21 · Adaptive Biotechnologies Corp

$136.5K

—

ADPTExercise

2025-11-21 · Adaptive Biotechnologies Corp

$5.2K

—

ADPTSell

2025-11-20 · Adaptive Biotechnologies Corp

$4.93M

—

ADPTExercise

2025-11-20 · Adaptive Biotechnologies Corp

$837.2K

—

ADPTExercise

2025-11-20 · Adaptive Biotechnologies Corp

$1.13M

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.